Try our beta test site
475 studies found for:    Non-Alcoholic Steatohepatitis
Show Display Options
Rank Status Study
21 Completed A One-Year, Randomized, Double-Blind, Placebo-Controlled Trial of Rosiglitazone in Non-Alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Intervention: Drug: rosiglitazone
22 Withdrawn Safety and Efficacy Study of IMM 124-E (Bovine Colostrum) for Patients With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis
Interventions: Biological: IMM 124-E;   Biological: Placebo
23 Completed Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without Cirrhosis
Condition: Nonalcoholic Steatohepatitis
Intervention: Drug: solithromycin
24 Withdrawn Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: pentoxiphylline and Vitamin E;   Drug: Vitamin E
25 Active, not recruiting A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis
Interventions: Drug: BMS-986036;   Drug: Placebo
26 Withdrawn Vitamin E Versus Vitamin E Plus Pentoxiphyllin in Patients With Nonalcoholic Steatohepatitis: A Prospective Randomized Clinical Trial
Condition: Non Alcoholic Steatohepatitis
Interventions: Drug: Vitamin E plus Pentoxiphyllin;   Drug: Vitamin E
27 Recruiting Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: SEL;   Drug: Placebo
28 Recruiting Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: SEL;   Drug: Placebo
29 Completed The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
Condition: Non Alcoholic Steatohepatitis
Interventions: Dietary Supplement: synbiotic;   Other: placebo
30 Completed Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis
Interventions: Drug: GS-9450;   Drug: GS-9450 Placebo
31 Unknown  The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis
Condition: Non-alcoholic Steatohepatitis
Interventions: Drug: S-adenosylmethionine (SAMe);   Drug: pentoxiphylline (PTX)
32 Completed A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831
Condition: Non-Alcoholic Steatohepatitis
Interventions: Drug: ASP9831;   Drug: Placebo
33 Completed Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Drug: GFT505 80mg;   Drug: GFT505 120mg;   Drug: Placebo
34 Completed The Impact of Deferasirox on Non-Alcoholic-Steatohepatitis
Conditions: Non-alcoholic Steatohepatitis;   Increased Iron Storage / Disturbed Distribution
Intervention: Drug: Exjade
35 Recruiting GS-0976 in Adults With Nonalcoholic Steatohepatitis
Condition: Nonalcoholic Steatohepatitis (NASH)
Interventions: Drug: GS-0976;   Drug: Placebo
36 Terminated Safety and Efficacy of Simtuzumab (GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
Condition: Non-Alcoholic Steatohepatitis (NASH)
Interventions: Biological: Simtuzumab;   Biological: Placebo
37 Recruiting Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Interventions: Drug: Elafibranor;   Drug: Placebo
38 Active, not recruiting A Phase ll Study of IMM-124E for Patients With Non-alcoholic Steatohepatitis
Condition: Non-alcoholic Steatohepatitis (NASH)
Interventions: Biological: IMM-124E;   Other: Placebo
39 Completed Effect of Fish-oil on Non-alcoholic Steatohepatitis (NASH)
Conditions: Non-alcoholic Fatty Liver Disease;   Non-alcoholic Steatohepatitis
Intervention: Other: Omega-3 capsules-Fish Oil
40 Recruiting Evaluating the Safety, Tolerability, and Efficacy of GS-9674 in Participants With Nonalcoholic Steatohepatitis (NASH)
Condition: Nonalcoholic Steatohepatitis (NASH)
Interventions: Drug: GS-9674;   Drug: Placebo to match GS-9674

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.